A fractional-order delay differential model with optimal control for cancer treatment based on synergy between anti-angiogenic and immune cell therapies (Q2206325)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: A fractional-order delay differential model with optimal control for cancer treatment based on synergy between anti-angiogenic and immune cell therapies |
scientific article; zbMATH DE number 7264119
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | A fractional-order delay differential model with optimal control for cancer treatment based on synergy between anti-angiogenic and immune cell therapies |
scientific article; zbMATH DE number 7264119 |
Statements
A fractional-order delay differential model with optimal control for cancer treatment based on synergy between anti-angiogenic and immune cell therapies (English)
0 references
22 October 2020
0 references
anti-angiogenic therapy
0 references
Hamiltonian
0 references
cancer treatment
0 references
fractional-calculus
0 references
delay differential equations
0 references
immunotherapy
0 references
optimal control
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0.884852945804596
0 references
0.8455962538719177
0 references
0.8143110275268555
0 references
0.8091292977333069
0 references
